← All organizations
Highest phase reached
Phase 1
First clinical trial
Apr 22, 2024Last known activity
Nov 30, 2024
Timeline
2010s
- Jan 1, 2016
Senti Biosciences— Founded
Drugs by trial phase (2 distinct, 2 trials)
Phase 1 (2 own, 0 via acquisition)
Recent trials (2)
- NCT06652243CollaboratorEarly Phase 1Nov 30, 2024
- NCT06325748Lead sponsorPhase 1Apr 22, 2024
Details
- Founded
- Cambridge, MA, US Jan 1, 2016
- Last known activity
- Nov 30, 2024